Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?

Phase 4WithdrawnNCT03020563

University of Minnesota

Overview

To determine whether liposomal bupivacaine wound infiltration decreases pain scores and narcotic use when compared to bupivacaine alone after open reduction internal fixation of midshaft clavicle fractures.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Clavicle Fracture

Interventions

Liposomal BupivacaineDRUG

Liposomal Bupivacaine

BupivacaineDRUG

Bupivacaine

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Mid-shaft Clavicle Fracture treated with ORIF Exclusion Criteria: * Unable to be contacted for 72 hours post surgery * Other concurrent surgical procedures * Chronic narcotic user

Locations (1)

University of Minnesota

Minneapolis, Minnesota, United States

Outcomes

Primary Outcomes

Visual Analogue Pain Scale Averages between the two treatments

Scale is based on 1-10 with 1 being the lowest pain and 10 being the highest pain.

Time frame: 72 hours post surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.